Marimed (MRMD) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Marimed faces the risk that failure to meet OTCQX continued listing standards, including minimum bid price, market capitalization, disclosure, governance, and market-maker requirements, could lead to a downgrade or removal of its common stock from the OTCQX marketplace. Such an event would likely reduce stock liquidity and visibility, hinder its access to capital and institutional investors, and negatively affect strategic flexibility, analyst coverage, and talent recruitment.
Overall, Wall Street has a Moderate Buy consensus rating on MRMD stock based on 1 Buy.
To learn more about Marimed’s risk factors, click here.